- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Small Practices and Dual Risk: Considerations and Approaches
Asking for help to prepare for the Enhancing Oncology Model (EOM) and 2-sided risk is advised, say panelists experienced with the Oncology Care Model (OCM).
EP: 1.No Successor to OCM Would Disappoint
EP: 2.CMMI Open to Feedback, but EOM Out of the Blue
EP: 3.Some Practices That Did Not Do OCM Are Applying
EP: 4.Seven Tumor Types: Pros and Cons
EP: 5.A Model That Is Built to “Win”
EP: 6.Addressing Health Equity and Social Needs
EP: 7.Is Five Years Long Enough?
EP: 8.Changes to MEOS and Barriers to Entry
EP: 9.Small Practices and Dual Risk: Considerations and Approaches
EP: 10.Does Pooling Make Sense?
EP: 11.What Would You Change About the EOM?
Moderator Stuart Staggs, MSIE, senior director, strategic programs, The US Oncology Network, asks the panel to discuss how small practices can approach the Enhancing Oncology Model (EOM), both from a care delivery standpoint and from the requirement to take on dual risk from the beginning. Panelists agreed that a laser focus on patient care and quality of life will help achieve the cost control needed for 2-sided risk. Stephen Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, urges practices to not be afraid to ask for help, whether it’s from the Community Oncology Alliance (COA) or from other practice leaders. Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates and COA president, said concentrating on keeping patients out of the hospital is key. If an oncologist can deliver more days at home with family, Patel said, “I’m doing my job.” Fred Divers, MD, chief medical officer, American Oncology Network and medical oncologist, Genesis Cancer and Blood Institute of Arkansas, agreed that emphasis on high-touch care delivery makes a difference, and so does having “skin in the game.”
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More
